About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada’s knowledge-based economy, contributing over $3 billion to the Canadian economy.  Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.

Our Mission

Advocate for policies that will bring the best innovative medicines and vaccines to Canadians in a timely and appropriate manner; improve Canada's global competitiveness; and make Canada a world leader in attracting pharmaceutical and biotechnology investments, which are key components of the knowledge-based economy.


Sustainability/Access - Improve patient access to new medicines and vaccines by driving recognition for their value as levers to better health outcomes and system sustainability.

Competitive Investment Environment - Strengthen Canada's position and capacity as a preferred destination for global life science investment.